Companies: 10,795·Total market cap: $144.5T
Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILDNASDAQHealthcare● Active
$129.16
$-0.02(-0.02%)
Market Cap$160.4B
P/E Ratio
52W High$157.29
52W Low$104.46
Overview

Gilead Sciences, Inc. (GILD) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GILD · as of Jun 8, 2026

Key Statistics

EPS (TTM)$7.42gild eps ttm · gild earnings per shareEarnings history
PE Ratio (TTM)17.4×gild pe ratio ttm · gild price to earningsPE Ratio deep dive
Revenue (TTM)$29.7Bgild revenue ttm · gild annual revenueFull revenue history
Dividend Yield2.49%does gild pay dividends · gild dividend yieldDividend history
Shares Outstanding1.24Bgild shares outstanding · gild floatShares outstanding history
Next EarningsAug 6, 2026Est.gild earnings date · gild next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$29.44B▲ +2.39% YoY
202320242025
gilead sciences, inc. revenue · gild revenue 2025
FY 2025Net Income$8.51B▲ +1672.92% YoY
202320242025
gilead sciences, inc. net income · gild profit 2025
FY 2025EPS$6.84▲ +1700.00% YoY
202320242025
gild eps · gilead sciences, inc. earnings per share 2025
TTM:Revenue: $29.73BNet Income: $9.22BEPS: $7.42View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy58 analystsis gild a buy · gild analyst rating
Strong Buy
0
Buy
39
Hold
18
Sell
1
Strong Sell
0
12-Month Price Target
$122.00Low
$129.16Current
$159.56Avg Target23.54% upside
$180.00High
gild price target · gild 12 month forecast

Total: 58 · Buy rate: 67.2%

The GILD analyst consensus is Buy, based on ratings from 58 Wall Street analysts over the past 3 months. The average 12-month price target is $159.56, representing +23.54% upside from the current price of $129.16.

Stock Performance

Full History
1D-0.02%
1W+1.23%
1M-1.65%
3M-10.26%
YTD+5.23%
1Y+14.30%
5Y+91.32%

About Gilead Sciences, Inc.

CEODaniel O'Day
IPO DateJan 22, 1992
Employees17,600
CountryUS
Websitegilead.com

Gilead Sciences, Inc. a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company …

what is gilead sciences, inc. · gild stock overview · gilead sciences, inc. company profile · who is gilead sciences, inc. ceo · gild NASDAQ · gilead sciences, inc. headquarters · gilead sciences, inc. business segments

About Stock Overview & Key Data

Gilead Sciences, Inc. (GILD) is a Healthcare company in the Drug Manufacturers - General industry, listed on NASDAQ since Jan 22, 1992. As of the latest trading session, GILD stock price is $129.16, with a market capitalization of $160.4B. The stock has returned +14.30% over the past 12 months and +5.23% year-to-date.

According to 58 Wall Street analysts, the consensus rating for Gilead Sciences, Inc. stock is Buy, with an average 12-month price target of $159.56. In fiscal year 2025, Gilead Sciences, Inc. reported revenue of $29.4B and net income of $8.5B. For detailed data — including Gilead Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Gilead Sciences, Inc. (GILD) stock price is $129.16. The stock is traded on NASDAQ under the ticker symbol GILD. The 52-week range is $104.46 – $157.29.

GILD stock priceGILD quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice